AbbVie Inc. vs Royal Bank of Canada
AbbVie Inc. is worth $464.575B, 1.6× the $287.952B market cap of Royal Bank of Canada. Updated daily.
| Metric | AbbVie Inc.ABBV  | |
|---|---|---|
| Market cap | $464.575B | $287.952B |
| Global rank | #1 | #2 |
| Share price | $262.90 | $207.21 |
| Change | +5.12% | -1.45% |
| Revenue | $61.160B | $46.873B |
| Net income | $4.226B | $14.345B |
| Country | United States | Canada |
| Sector | Healthcare | Financial Services |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is AbbVie Inc. bigger than Royal Bank of Canada?
- AbbVie Inc. has a market cap of $464.575B against $287.952B for Royal Bank of Canada, making it 1.6 times as valuable.
- Which company earns more, ABBV or RY?
- AbbVie Inc. reported net income of $4.226B and Royal Bank of Canada reported $14.345B in their most recent annual periods.